Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Glycocore Pharma Logo
Glycocore Pharma CB Rank
2868733
Heat Score
59
Glycocore Pharma is a chemical manufacturing company that creates biopolymers for the treatment of respiratory illnesses.
Founded
obfuscation
Private Como, Lombardia, Italy1-10 www.glycocore-ph.com/
Chemical
Medical
Therapeutics
Overview

Glycocore Pharma
Heat Score
59

Growth Score
pts
in past quarter
Heat Score 59
-10 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Glycocore Pharma

CB Rank
2868733
Glycocore Pharma is a chemical manufacturing company that creates biopolymers for the treatment of respiratory illnesses.
Founded
obfuscation
Private Como, Lombardia, Italy1-10 www.glycocore-ph.com/
Chemical
Medical
Therapeutics

Details

Legal Name Glycocore Pharma srl
Operating Status Active
Company Type For Profit
Phone Number +39 03987290131
Contact Email info@glycocore-ph.com
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

HYLACH®
A biopolymeric molecule composed of hyaluronic acid conjugated with lactose derivatives, designed to interact with Galectin-3 to modulate fibrotic and inflammatory processes in respiratory diseases.
Idiopathic Pulmonary Fibrosis (IPF) Treatment
Development of biopolymers for treating IPF, a chronic lung disorder characterized by progressive fibrosis and high lethality.

Research & Development

Glycocore Pharma is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10
News

News and Press

News•Apr 19, 2022
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Active Website Tech Count

5Glycocore Pharma is actively using 5 technologies for its website, according to BuiltWith. These include SSL by Default, nginx, and  CloudFront.

Total IP

2The intellectual property of Glycocore Pharma includes 2 registered patents primarily in the 'Organic Macromolecular Compounds; Their Preparation Or Chemical Working-Up' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Glycocore Pharma's headquarters? Glycocore Pharma is located in Como, Lombardia, Italy.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(8fe006b 1)
|